Rose Sharon Shabet, 10% Owner at BridgeBio Pharma, Inc. (BBIO), bought 14,884,854 shares at $17.00 ($80.0M) on 2019-06-27, disclosed to the SEC on 2019-06-28.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 10,178,954 | $0 | 0.0% |
| 2 | $17.00 | 4,705,900 | $80.0M | 100.0% |
| Total | $5.37 avg | 14,884,854 | $80.0M | 100% |
| Filing → |
| FIGS | SELL | 2021-09-03 | $18.7M | — | Filing → |
| UROV | BUY | 2019-06-14 | $177K | — | Filing → |